SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-08-011239
Filing Date
2008-09-22
Accepted
2008-09-22 10:57:38
Documents
3
Period of Report
2008-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y00172e8vk.htm 8-K 10252
2 EX-99.1: PRESS RELEASE y00172exv99w1.htm EX-99.1 2997
3 EX-99.2: PRESS RELEASE y00172exv99w2.htm EX-99.2 5816
  Complete submission text file 0000950123-08-011239.txt   20850
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 081081672
SIC: 2836 Biological Products, (No Diagnostic Substances)